I now have comprehensive content. Let me compile the full answer.
Clinical Case: Painless Vesicular Lesion in a Sheep Farm Worker
a) Clinical Condition
Cutaneous Anthrax (also called "Malignant Pustule")
The key diagnostic clues are:
- Occupation: sheep farm worker (primary animal reservoir for Bacillus anthracis)
- Painless (a hallmark feature), itchy vesicular lesion on the forearm (exposed area)
- No systemic symptoms (fever, myalgia) - consistent with localised cutaneous form
- Gram stain: spore-forming Gram-positive bacilli = Bacillus anthracis
Anthrax is primarily a disease of herbivorous animals (sheep, cattle, horses, goats), and humans acquire it through occupational exposure to infected animals or their products (hides, wool, bone meal). This is why it was historically called "woolsorter's disease" or "ragpicker's disease". Cutaneous anthrax accounts for approximately 95% of all human anthrax cases worldwide. (Andrews' Diseases of the Skin; Dermatology 5e)
b) Clinical Presentations of Anthrax
Anthrax occurs in four main clinical forms depending on the route of infection:
1. Cutaneous Anthrax (~95% of cases)
The most common and least lethal form. Classic progression:
| Stage | Time | Appearance |
|---|
| Papule | Day 1-3 post-inoculation | Purpuric macule/papule resembling insect bite; pruritic |
| Vesicle | Within 48 hours | 1-3 mm vesicle forms with surrounding non-pitting edema |
| Ulcer + Satellite vesicles | Day 3-5 | Central vesicle ulcerates; small ring of vesicles ("pearly wreath") forms around it |
| Black Eschar | Day 5-7 | Painless, depressed, coal-black necrotic eschar with intense surrounding erythema and edema |
| Resolution | Week 1-2 | Eschar dries, loosens, and sloughs; heals without permanent scar |
Key features:
- Painlessness of the lesion despite necrosis (diagnostically important - helps distinguish from brown recluse spider bite which is painful)
- Marked surrounding non-pitting edema (may be massive, especially on face/neck)
- Regional lymphangitis and lymphadenopathy (tender, enlarged, may suppurate)
- Without treatment, up to 20% mortality (from septicaemia); near-zero mortality with antibiotics
- Note: antibiotic therapy does not alter the progression of the local lesion (toxin-mediated), but prevents systemic dissemination (Dermatology 5e)
2. Inhalational Anthrax ("Woolsorter's Disease") - Most lethal form
- Caused by inhalation of spores (aerosols from infected hides/wool, or bioterrorism)
- Spores are phagocytosed by alveolar macrophages, transported to mediastinal lymph nodes where they germinate
- Biphasic illness:
- Phase 1 (2-10 days): Flu-like illness - malaise, fever, non-productive cough; may mimic influenza
- Phase 2 (abrupt deterioration within 24-48 hours): Overwhelming sepsis, shock, haemorrhagic mediastinitis, respiratory distress, stridor
- CXR/CT: widened mediastinum, hilar adenopathy, pleural effusions (haemorrhagic)
- Mortality: ~50% even with intensive treatment; without treatment near 100%
3. Gastrointestinal Anthrax
- From ingestion of undercooked contaminated meat
- Two sub-forms:
- Oropharyngeal: Sore throat, neck swelling (cervical lymphadenitis), tonsil involvement, fever, dysphagia, respiratory distress
- Intestinal: Nausea, vomiting, fever → severe abdominal pain, haematemesis, ascites, bloody diarrhoea, acute abdomen (mesenteric lymphadenitis)
- Incubation: 2-5 days
- Mortality: approximately 50% (Rosen's Emergency Medicine)
4. Injection Anthrax
- Complication of intravenous drug use (primarily heroin)
- More than 50 cases in the UK and Germany
- Presents with fever and soft-tissue swelling/infection of an extremity
- Can cause deep tissue infection and septicaemia
c) Laboratory Diagnosis of Anthrax
Specimen Collection
- Vesicle fluid aspirate (as in this case) - collected before antibiotic therapy if possible
- Swab from base of ulcer/beneath eschar for cutaneous anthrax
- Blood cultures (bacteraemia)
- Sputum/BAL for inhalational anthrax
- Biopsy (punch biopsy) for histology, immunohistochemistry, and PCR
Biosafety note: Suspected anthrax specimens must be handled with BSL-3 precautions. Laboratory must be notified in advance.
1. Direct Microscopy (Gram Stain)
- Smear prepared from vesicle fluid
- Result: Large, square-ended, Gram-positive bacilli (rod-shaped), occurring singly or in pairs in clinical material; may form long bamboo-like chains on artificial media
- Spores visible - located centrally or sub-terminally, do not distend the cell
- Organisms are encapsulated (capsule visible with M'Fadyean's methylene blue stain - shows blue rods within pink/purple capsular "halo")
- Note: On Gram stain, the organisms are numerous and easily seen in lesion material (Andrews' Diseases of the Skin)
2. Culture
| Medium | Appearance | Notes |
|---|
| Blood agar (BAP) | Large (2-5 mm), grey-white, opaque, irregular "medusa head" or "comet tail" colonies; non-haemolytic | Non-haemolysis distinguishes it from B. cereus (which is beta-haemolytic) |
| Nutrient agar | Rough, dull, flat colonies with irregular edges | Spore formation enhanced |
| PLET agar (Polymyxin-Lysozyme-EDTA-Thallous acetate) | Selective medium for B. anthracis | Ground glass appearance |
- Incubation: 37°C aerobic, 18-24 hours
- On prolonged incubation or growth at <37°C, spores form
- B. anthracis colonies show a characteristic "beaten-egg-white" consistency and when teased with a loop, strands stand up and fall back ("stringy" or "tenacious" consistency - negative gamma phage test is key)
3. Identification Tests
| Test | Result in B. anthracis | Significance |
|---|
| Gram stain | Large Gram-positive rods, central/subterminal spores | Morphological ID |
| Capsule staining (M'Fadyean's polychrome methylene blue) | Positive - blue bacilli with pink capsule halo | Specific for B. anthracis |
| Motility | Non-motile | Distinguishes from other Bacillus spp. which are motile |
| Haemolysis | Non-haemolytic | B. cereus = beta-haemolytic |
| Catalase | Positive | All Bacillus spp. are catalase-positive |
| String of pearls test (penicillin agar) | Positive - chains of spherical protoplasts like a string of pearls | Highly characteristic for B. anthracis |
| Gamma phage lysis | Susceptible (lysed by gamma phage) | Specific confirmatory test |
| Gelatin hydrolysis | Positive (inverted pine-tree pattern) | Biochemical test |
| Bicarbonate agar (CO₂) | Forms mucoid colonies (capsule production) | Virulence testing |
4. Molecular and Advanced Tests
- PCR - detects specific genes: pagA (protective antigen), cya (edema factor), lef (lethal factor), capA/B/C (capsule genes)
- Immunohistochemistry (IHC) on biopsy - detects B. anthracis antigens in tissue
- ELISA / Western blot - serology for anti-protective antigen (PA) antibodies; become positive from day 10 onwards, peak at day 40
- MALDI-TOF mass spectrometry - rapid species identification
5. Antibiotic Susceptibility
- Sensitive to: ciprofloxacin, doxycycline, penicillin (natural strains), clindamycin, amoxicillin
- First-line treatment: ciprofloxacin or doxycycline (for 7-10 days for cutaneous; 60 days if inhalational co-exposure)
d) Zoonosis - Definition and Five Examples
Definition
A zoonosis (plural: zoonoses) is an infectious disease that is naturally transmissible from vertebrate animals to humans (and vice versa). The term was coined by Rudolf Virchow. The animal acts as the reservoir host, and humans are usually incidental/dead-end hosts.
Zoonoses may be transmitted by:
- Direct contact with animals, their secretions, excretions, or tissues (e.g., anthrax, brucellosis, rabies)
- Indirect contact via contaminated environment, soil, water, food (e.g., leptospirosis)
- Vector-borne transmission via arthropods (e.g., ticks, mosquitoes, fleas) - these are also called arboviruses when transmitted by arthropod vectors
- Inhalation of infected aerosols or spores (e.g., anthrax, Q fever, hantavirus)
- Ingestion of contaminated food/water (e.g., salmonellosis, brucellosis)
Zoonoses are of major public health significance since ~75% of emerging infectious diseases in humans are zoonotic in origin.
Five Important Zoonotic Diseases and Their Causative Agents
| # | Disease | Causative Agent | Animal Reservoir | Transmission to Humans |
|---|
| 1 | Anthrax | Bacillus anthracis (spore-forming Gram-positive bacillus) | Sheep, cattle, horses, goats | Contact with infected animals/hides/wool; inhalation of spores; ingestion |
| 2 | Rabies | Rabies virus (Rhabdoviridae, Lyssavirus) | Dogs, bats, foxes, jackals, raccoons | Bite/scratch from infected animal; saliva contact with mucous membranes |
| 3 | Brucellosis | Brucella spp. (B. melitensis - goats; B. abortus - cattle; B. suis - pigs) | Cattle, goats, sheep, pigs, dogs | Contact with infected animals (aborted foetuses, placenta); ingestion of unpasteurised milk/cheese; inhalation |
| 4 | Plague | Yersinia pestis (Gram-negative bacillus) | Rodents (rats, ground squirrels) | Bite of infected fleas (Xenopsylla cheopis); direct contact with infected tissue; inhalation (pneumonic plague) |
| 5 | Leptospirosis ("Weil's disease") | Leptospira interrogans (spirochaete) | Rats, cattle, dogs, pigs | Contact with water/soil contaminated with infected animal urine; through skin abrasions or mucous membranes |
Additional important zoonoses worth noting:
- Q fever - Coxiella burnetii; sheep/cattle; inhalation of birth products
- Salmonellosis - Salmonella spp.; poultry, reptiles; ingestion
- Toxoplasmosis - Toxoplasma gondii; cats; ingestion of oocysts/undercooked meat
- Cat scratch disease - Bartonella henselae; cats; scratch/bite
Summary for This Case
| Feature | Finding |
|---|
| Clinical condition | Cutaneous Anthrax |
| Causative organism | Bacillus anthracis |
| Gram stain | Large, Gram-positive, spore-forming bacilli |
| Key identifying features | Non-motile, non-haemolytic, coagulase-negative, capsulated; sensitive to gamma phage; "string of pearls" test positive |
| Confirmatory test | Gamma phage lysis, PCR, capsule staining (M'Fadyean's) |
| Treatment | Ciprofloxacin or Doxycycline for 7-10 days |
| Disease category | Zoonosis (animal source: sheep) |
Sources: Andrews' Diseases of the Skin 13e; Dermatology 2-Volume Set 5e; Rosen's Emergency Medicine 9e; Medical Microbiology 9e (Murray)